CVE-2016-5084 in Animas OneTouch Ping
Summary
by MITRE
Johnson & Johnson Animas OneTouch Ping devices do not use encryption for certain data, which might allow remote attackers to obtain sensitive information by sniffing the network.
If you want to get best quality of vulnerability data, you may have to visit VulDB.
Analysis
by VulDB Data Team • 11/03/2024
The Johnson & Johnson Animas OneTouch Ping diabetes management device represents a critical security vulnerability classified as CVE-2016-5084, where the medical device fails to implement encryption for specific data transmissions. This vulnerability resides within the wireless communication protocols of the device, which operates in the healthcare sector and handles sensitive patient information including glucose monitoring data, treatment parameters, and personal health metrics. The absence of encryption creates an exploitable condition that directly violates fundamental security principles governing medical device communications and data protection.
The technical flaw manifests in the device's wireless communication stack where certain data packets are transmitted in plaintext format over unencrypted channels. This weakness allows malicious actors positioned within network range to intercept and analyze the transmitted information through standard network sniffing tools. The vulnerability specifically affects the device's communication with companion applications and healthcare providers, where sensitive medical data flows through wireless networks without proper cryptographic protection. This issue aligns with CWE-312, which addresses the exposure of sensitive information through improper encryption or lack of encryption mechanisms, and represents a fundamental failure in implementing secure communication protocols.
The operational impact of this vulnerability extends beyond simple data exposure, as it creates potential pathways for unauthorized access to critical patient health information. Attackers could potentially manipulate treatment data, gain insights into patient medical conditions, or even interfere with device operations that could affect patient safety. The remote nature of the attack vector means that adversaries do not require physical access to the device or specialized equipment beyond basic network monitoring capabilities. This vulnerability particularly impacts the healthcare industry's adherence to HIPAA regulations and other data protection frameworks, as the exposed data could constitute protected health information requiring strict confidentiality measures.
Mitigation strategies for this vulnerability must address both immediate and long-term security concerns within the medical device ecosystem. Organizations should implement network segmentation to isolate medical devices from general corporate networks, deploy wireless intrusion detection systems to monitor for suspicious activity, and establish strict access controls for device management interfaces. The remediation process requires device manufacturers to update firmware with proper encryption protocols and ensure all data transmission channels employ strong cryptographic measures. Security professionals should reference ATT&CK technique T1041 for network sniffing activities and consider implementing network traffic analysis to detect anomalous communication patterns. Additionally, healthcare organizations must conduct regular security assessments of connected medical devices and establish incident response procedures specifically tailored to medical device security breaches. The vulnerability demonstrates the critical importance of security by design principles in medical devices, where the failure to implement basic encryption mechanisms can have severe consequences for patient privacy and safety.